SPONSOR

University Medical Center Groningen

Total Trials

Recruiting

Phases

Phase 2, Phase 4, Phase 3, Phase 2, Phase 3

Conditions studied: Coronary Artery Disease Coronary Artery Disease (CAD)Multivessel Coronary Artery Disease CABG CABG in Low EF Heart Failure PCI Revascularization Head and Neck Neoplasms MSI-H Cancer

University Medical Center Groningen is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Coronary Artery Disease, Coronary Artery Disease (CAD), Multivessel Coronary Artery Disease, CABG.

The trial portfolio spans Phase 2, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Medical Center Groningen

How many clinical trials has University Medical Center Groningen sponsored?

ClinicalMetric currently tracks 16 clinical trials sponsored by University Medical Center Groningen, of which 16 are actively recruiting participants. These trials cover conditions including Coronary Artery Disease, Coronary Artery Disease (CAD), Multivessel Coronary Artery Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Medical Center Groningen research focus on?

University Medical Center Groningen clinical trials span Coronary Artery Disease, Coronary Artery Disease (CAD), Multivessel Coronary Artery Disease, CABG, CABG in Low EF, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Medical Center Groningen clinical trial?

To participate in a University Medical Center Groningen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Medical Center Groningen trials with current recruitment status updated daily.

University Medical Center Groningen

Frequently Asked Questions — University Medical Center Groningen

Clinical Trials by University Medical Center Groningen

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

Diaphragm Paralysis: Surgery or Mechanical Ventialion

The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

Validation of the Dutch Translation of the Prosthesis Evaluation Questionnaire

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF

No Guts No Glory Probiotics

Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences

Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study

EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors

Bronchoscopic EmphysemA Treatment in THE NetherLands